Colgate-Palmolive (NYSE:CL) Stake Reduced by Kathmere Capital Management LLC

Kathmere Capital Management LLC decreased its position in shares of Colgate-Palmolive (NYSE:CL) by 7.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 12,809 shares of the company’s stock after selling 1,085 shares during the quarter. Kathmere Capital Management LLC’s holdings in Colgate-Palmolive were worth $1,164,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Reston Wealth Management LLC bought a new position in shares of Colgate-Palmolive in the third quarter worth $42,000. Capital Performance Advisors LLP bought a new position in shares of Colgate-Palmolive during the 3rd quarter valued at about $53,000. Prospera Private Wealth LLC acquired a new position in shares of Colgate-Palmolive in the 3rd quarter worth approximately $64,000. True Wealth Design LLC raised its holdings in shares of Colgate-Palmolive by 1,460.9% in the 3rd quarter. True Wealth Design LLC now owns 718 shares of the company’s stock worth $75,000 after purchasing an additional 672 shares in the last quarter. Finally, Continuum Advisory LLC raised its holdings in shares of Colgate-Palmolive by 93.4% in the 3rd quarter. Continuum Advisory LLC now owns 762 shares of the company’s stock worth $79,000 after purchasing an additional 368 shares in the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms have issued reports on CL. TD Cowen decreased their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, January 8th. Piper Sandler reduced their price objective on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. JPMorgan Chase & Co. boosted their target price on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. StockNews.com lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. Finally, Stifel Nicolaus cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and decreased their target price for the stock from $105.00 to $101.00 in a report on Monday, October 28th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $103.63.

Colgate-Palmolive Trading Up 0.7 %

Colgate-Palmolive stock opened at $87.73 on Wednesday. Colgate-Palmolive has a one year low of $79.69 and a one year high of $109.30. The company’s fifty day moving average price is $92.36 and its two-hundred day moving average price is $97.92. The company has a market capitalization of $71.68 billion, a price-to-earnings ratio of 25.14, a PEG ratio of 3.31 and a beta of 0.44. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.28%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is currently 57.31%.

Insider Activity at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. This represents a 55.29 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.37% of the stock is currently owned by company insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.